Ordering Recommendation
Recommendations when to order or not order the test. May include related or preferred tests. Use to monitor treatment of individuals with classic or nonclassic congenital adrenal hyperplasia.
Mnemonic
Unique test identifier. CAH RX PANEL
Methodology
Process(es) used to perform the test. Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
Performed
Days of the week the test is performed.
Reported
Expected turnaround time for a result, beginning when ARUP has received the specimen.
New York DOH Approval Status
Indicates test has been approved by the New York State Department of Health. This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect between 6-10 a.m.
Collect
Serum separator tube or green (sodium or lithium heparin). Also acceptable: Pink (K2 EDTA).
Specimen Preparation
Transfer 1.2 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.7 mL)
Storage/Transport Temperature
Stability
Ambient: 24 hours; Refrigerated: 1 week; Frozen: 6 months
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges. Test Number
Components
Reference Interval
2001638 Androstenedione
Effective August 19, 2013Age
Female
Male
Premature Infants, 26-28 weeks-Day 4
0.92-2.82 ng/mL
0.92-2.82 ng/mL
Premature Infants, 31-35 weeks-Day 4
0.80-4.46 ng/mL
0.80-4.46 ng/mL
Full-term Infants, 1-7 days
0.20-2.90 ng/mL
0.20-2.90 ng/mL
8-30 days
0.18-0.80 ng/mL
0.18-0.80 ng/mL
1-5 months
0.06-0.68 ng/mL
0.06-0.68 ng/mL
6-24 months
Less than 0.15 ng/mL
0.03-0.15 ng/mL
2-3 years
Less than 0.16 ng/mL
Less than 0.11 ng/mL
4-5 years
0.02-0.21 ng/mL
0.02-0.17 ng/mL
6-7 years
0.02-0.28 ng/mL
0.01-0.29 ng/mL
8-9 years
0.04-0.42 ng/mL
0.03-0.30 ng/mL
10-11 years
0.09-1.23 ng/mL
0.07-0.39 ng/mL
12-13 years
0.24-1.73 ng/mL
0.10-0.64 ng/mL
14-15 years
0.39-2.00 ng/mL
0.18-0.94 ng/mL
16-17 years
0.35-2.12 ng/mL
0.30-1.13 ng/mL
18-39 years
0.26-2.14 ng/mL
0.33-1.34 ng/mL
40 years and older
0.13-0.82 ng/mL
0.23-0.89 ng/mL
Pre-menopausal
0.26-2.14 ng/mL
Does Not Apply
Postmenopausal
0.13-0.82 ng/mL
Does Not Apply
Tanner Stage I
0.05-0.51 ng/mL
0.04-0.32 ng/mL
Tanner Stage II
0.15-1.37 ng/mL
0.08-0.48 ng/mL
Tanner Stage III
0.37-2.24 ng/mL
0.14-0.87 ng/mL
Tanner Stage IV-V
0.35-2.05 ng/mL
0.27-1.07 ng/mL
0092332 17-Hydroxyprogesterone Quantitative by HPLC-MS/MS, Serum or Plasma
Effective August 19, 2013Age
Female
Male
Premature (26-28 weeks)
124-841 ng/dL
124-841 ng/dL
Premature (29-35 weeks)
26-568 ng/dL
26-568 ng/dL
Full term Day 3
7-77 ng/dL
7-77 ng/dL
4 days-30 days
7-106 ng/dL
Less than 200 ng/dL
1 month-2 months
13-106 ng/dL
Less than 200 ng/dL
3 months-5 months
13-106 ng/dL
3-90 ng/dL
6 months-1 year
Less than or equal to 148 ng/dL
Less than or equal to 148 ng/dL
2-3 years
Less than or equal to 256 ng/dL
Less than or equal to 228 ng/dL
4-6 years
Less than or equal to 299 ng/dL
Less than or equal to 208 ng/dL
7-9 years
Less than or equal to 71 ng/dL
Less than or equal to 63 ng/dL
10-12 years
Less than or equal to 129 ng/dL
Less than or equal to 79 ng/dL
13-15 years
9-208 ng/dL
9-140 ng/dL
16-17 years
Less than or equal to 178 ng/dL
24-192 ng/dL
18 years and older
Less than 207 ng/dL
Less than 139 ng/dL
Follicular
15-70 ng/dL
Does Not Apply
Luteal
35-290 ng/dL
Does Not Apply
Tanner Stage I
Less than or equal to 74 ng/dL
Less than or equal to 62 ng/dL
Tanner Stage II
Less than or equal to 164 ng/dL
Less than or equal to 104 ng/dL
Tanner Stage III
13-209 ng/dL
Less than or equal to 151 ng/dL
Tanner Stage IV-V
7-170 ng/dL
20-173 ng/dL
0081058 Testosterone, Females or Children
Effective August 19, 2013Age
Female
Male
Premature (26-28 weeks)
5-16 ng/dL
59-125 ng/dL
Premature (31-35 weeks)
5-22 ng/dL
37-198 ng/dL
Newborn
20-64 ng/dL
75-400 ng/dL
1-5 months
Less than 20 ng/dL
14-363 ng/dL
6-24 months
Less than 9 ng/dL
Less than 37 ng/dL
2-3 years
Less than 20 ng/dL
Less than 15 ng/dL
4-5 years
Less than 30 ng/dL
Less than 19 ng/dL
6-7 years
Less than 7 ng/dL
Less than 13 ng/dL
8-9 years
1-11ng/dL
2-8 ng/dL
10-11 years
3-32 ng/dL
2-165 ng/dL
12-13 years
6-50 ng/dL
3-619 ng/dL
14-15 years
6-52 ng/dL
31-733 ng/dL
16-17 years
9-58 ng/dL
158-826 ng/dL
18-39 years
9-55 ng/dL
300-1080 ng/dL
40-59 years
9-55 ng/dL
300-890 ng/dL
60 years and older
5-32 ng/dL
300-720 ng/dL
Premenopausal (18 years and older)
9-55 ng/dL
Does Not Apply
Postmenopausal
5-32 ng/dL
Does Not Apply
Tanner Stage I
2-17 ng/dL
2-15 ng/dL
Tanner Stage II
5-40 ng/dL
3-303 ng/dL
Tanner Stage III
10-63 ng/dL
10-851 ng/dL
Tanner Stage IV-V
11-62 ng/dL
162-847 ng/dL
Interpretive Data
Background information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results. Total testosterone values may not reflect optimal concentrations in all individuals. Free or bioavailable testosterone measurements may provide supportive information.
Compliance Category
Laboratory Developed Test (LDT)
Note
Additional information related to the test.
CPT Codes
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually.
Components
Components of test Component Test Code*
Component Chart Name
LOINC
0081058
Testosterone, LC-MS/MS
2986-8
0092332
17-Hydroxyprogesterone, HPLC-MS/MS
1668-3
2001639
Androstenedione by TMS
1854-9
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Other names that describe the test. Synonyms. 17-Hydroxyprogesterone (Congenital Adrenal Hyperplasia Treatment Panel)
Androstenedione (Congenital Adrenal Hyperplasia Treatment Panel)
Testosterone (Congenital Adrenal Hyperplasia Treatment Panel)
Congenital Adrenal Hyperplasia Treatment Panel
Chat
Feedback
